Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

 ;Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology, will be exhibiting at the Society of Nuclear Medicine (SNM 2011) Annual Meeting, to be held in San Antonio, TX, June  4th through 8th, 2011.

Patrick G. Rooney, CEO of Positron, stated, "With the increased interest in cardiac PET and the launch of the PosiRx system, our participation at well-respected forums such as SNM is crucial to meeting customers and creating market awareness.  After attendance at the American College of Cardiologists conference in April and the more recent International Conference of Non-Cardiovascular Imaging in Europe, we have seen a notable increase in interest levels for both the cardiac PET and SPECT pharmaceutical segments of our business.  The exposure and introductions gained from these industry conferences have yielded opportunities that will advance our future growth."

Founded in 1954, the SNM is an international scientific and professional organization that promotes the science, technology and practical application of nuclear medicine.  Its 16,000 members are physicians, technologists and scientists that specialize in the research and practice of nuclear medicine. The Society maintains an active advocacy program which promotes and encourages research for the advancement of nuclear medicine science, producing a number of programs to help physicians and technologists remain current on latest advancements.  The Society also sponsors educational programs for consumers to help them understand nuclear medicine and the constructive role it can play in both diagnostic and therapeutic therapies.

Source: Positron